SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotech & Pharma.T.A,
BIB 80.830.0%Jan 16 4:00 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Jibacoa who wrote (592)7/29/2004 1:31:23 PM
From: Jibacoa  Read Replies (1) of 3722
 
BIOM Is trading above $1 again today, after the news that PRR's subsidiary, CancerVac started a PII on patients with ovarian cancer using rights to the MUC1 protein which they had licensed from BIOM and also the announcement earlier this week that they have completed enrolment in the PII of Theratope for women with metastatic breast cancer who are concurrently being treated with an estrogen-receptor antagonist. (On the earlier PIII of Theratope there was a group of patients that were also receiving hormonal therapy, and showed what appeared to be statistically positive results.)

bigcharts.marketwatch.com

Bernard
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext